Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS)

CNY 37.71

(-1.33%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.86 Billion 1.46 Billion 1.24 Billion 384.85 Million 285.51 Million 201.49 Million
Total Current Assets 1.35 Billion 1.03 Billion 941.78 Million 262.87 Million 181.53 Million 119.07 Million
Cash And Short Term Investments 720.93 Million 622.03 Million 647.85 Million 109.3 Million 76.48 Million 31.7 Million
Cash and Cash Equivalents 690.93 Million 608.92 Million 490.25 Million 109.3 Million 76.48 Million 31.7 Million
Short Term Investments 30 Million 13.1 Million 157.6 Million 5.09 Million - 70 Thousand
Net Receivables 555.83 Million 400.16 Million 277.14 Million 130.74 Million 94.52 Million -
Inventory 14.4 Million 12.53 Million 7.84 Million 6.28 Million 3.74 Million 3.89 Million
Other Current Assets 9.55 Million 5.22 Million 8.94 Million 16.53 Million 6.77 Million 3.78 Million
Total Non-Current Assets 505.88 Million 423.13 Million 300.86 Million 121.98 Million 103.98 Million 82.42 Million
Net PPE 220.26 Million 197.01 Million 161.05 Million 74.64 Million 63.09 Million 50.9 Million
Good Will And Intangible Assets 31.44 Million 30.25 Million 29.38 Million 30.09 Million 24.56 Million 22.2 Million
Good Will 26.05 Million 26.05 Million 26.05 Million 26.05 Million 20.51 Million 20.51 Million
Intangible Assets 5.38 Million 4.19 Million 3.32 Million 4.04 Million 4.05 Million 1.69 Million
Long-Term Investments 100.85 Million 81.64 Million -117.6 Million 13.15 Million 12.86 Million 3.96 Million
Tax Assets 38.92 Million 16.08 Million 5.03 Million 2.65 Million 1.97 Million 2.32 Million
Other Non Current Assets 114.38 Million 98.13 Million 222.99 Million 1.42 Million 1.48 Million 3.02 Million
Other Assets 1.00 - 1.00 - - -
Total Liabilities 805.75 Million 554.86 Million 473 Million 191.93 Million 166.75 Million 127.67 Million
Total Current Liabilities 761.2 Million 518.19 Million 417.82 Million 191.93 Million 166.75 Million 123.81 Million
Account Payables 56.76 Million 33.03 Million 18.35 Million 13.62 Million 15.84 Million 8.79 Million
Tax Payables 30.51 Million 20.87 Million 17.47 Million 7.12 Million 4.8 Million 3.96 Million
Short Term Debt 406.02 Million 223.7 Million 156.98 Million 23.5 Million 15.86 Million 4.87 Million
Deferred Revenue 292.66 Million 205.85 Million 238.14 Million 152.57 Million 22.49 Million 3.96 Million
Other Current Liabilities 5.74 Million 55.59 Million 4.34 Million 2.23 Million 112.56 Million 106.17 Million
Total Non Current Liabilities 44.55 Million 36.66 Million 55.18 Million 31.01 Million - 3.86 Million
Long-Term Debt 40.62 Million 33.84 Million 49.72 Million 31.01 Million - 3.86 Million
Deferred Revenue Non Current 3.58 Million 2.82 Million 5.46 Million - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - 2.82 Million 5.46 Million - - -
Other Liabilities 1.00 - - -31.01 Million - 1.00
Total Equity 1.05 Billion 908.23 Million 769.64 Million 192.91 Million 118.75 Million 73.82 Million
Stock Holders Equity 1.04 Billion 896.69 Million 761.94 Million 189.1 Million 116.63 Million 75.23 Million
Common Stock 112 Million 80 Million 80 Million 60 Million 16.3 Million 16.3 Million
Retained Earnings 415.88 Million 293.5 Million 171.29 Million 73.1 Million 72.18 Million 27.94 Million
Accumulated other comprehensive income - 23.35 Million 10.8 Million 6.66 Million 28.15 Million 30.98 Million
Common Stock Equity 1.04 Billion 896.69 Million 761.94 Million 189.1 Million 116.63 Million 75.23 Million
Capital Lease Obligation 40.62 Million 33.84 Million 49.72 Million 31.01 Million - -
Total Investments 100.85 Million 94.75 Million 40 Million 13.15 Million 12.86 Million 3.96 Million
Total Debt 446.65 Million 257.55 Million 206.7 Million 23.5 Million 15.86 Million 4.87 Million
Net Debt -244.27 Million -351.37 Million -283.54 Million -85.8 Million -60.62 Million -26.82 Million

Balance Sheet Charts